FDNA launches online genetic counseling packages in order to improve access to essential genetic counseling services.

April 29, 2021

PRNewswire 

“FDNA helps remove wait times for a genetic counselor nearby and allows patients to look further afield for a genetic counselor, regardless of where the patient or counselor is in the world. This creates access to a broader pool of genetic experts and helps patients secure appointments faster. It also helps reduce costs and may ensure more competitive pricing for genetic counseling services as well.”

 

The article examines the challenges faced in accessing genetic counseling services and highlights the contributions of FDNA in overcoming these barriers. By leveraging AI, FDNA enhances the accessibility and effectiveness of genetic counseling. Their platform aids counselors by providing precise phenotypic and genotypic analysis, facilitating early diagnosis and personalized care. FDNA’s innovations are crucial in democratizing genetic counseling, ensuring that more patients can benefit from early detection and intervention for genetic disorders, irrespective of geographical or financial constraints.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading